169 related articles for article (PubMed ID: 21495249)
1. Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line.
Han B; Xiang Y; Wang Y; Wang Z; Zhang H; Huang S
Int J Gynecol Cancer; 2010 Oct; 20(7):1259-63. PubMed ID: 21495249
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase mRNA expression does not predict resistance to floxuridine in a choriocarcinoma cell line.
Han B; Xiang Y; Sha GH; Zhang H; Liu X
J Reprod Med; 2010; 55(5-6):247-52. PubMed ID: 20626181
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
Sakai K
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-resistant mechanisms in human choriocarcinoma cells.
Sakai K; Wake N; Fujino T; Yasuda T; Kato H; Fujimoto S; Fujinaga K
Gynecol Oncol; 1989 Jul; 34(1):7-11. PubMed ID: 2737530
[TBL] [Abstract][Full Text] [Related]
5. [MTX resistant mechanisms in human choriocarcinoma cells].
Sakai K; Fujino T; Hoshi S; Shinkai N; Hashimoto M; Yasuda T; Kato H; Yamada H; Wake N; Ichinoe K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):807-14. PubMed ID: 3474305
[TBL] [Abstract][Full Text] [Related]
6. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
Serra M; Reverter-Branchat G; Maurici D; Benini S; Shen JN; Chano T; Hattinger CM; Manara MC; Pasello M; Scotlandi K; Picci P
Ann Oncol; 2004 Jan; 15(1):151-60. PubMed ID: 14679136
[TBL] [Abstract][Full Text] [Related]
7. [Expression of C1QBP gene and its correlation with drug resistance in human resistance choriocarcinoma cell line].
Shen X; Han B; Shen Y; Yang J; Ren T; Sha G; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):616-20. PubMed ID: 25354864
[TBL] [Abstract][Full Text] [Related]
8. Dihydrofolate Reductase and Thymidylate Synthase Transgenes Resistant to Methotrexate Interact to Permit Novel Transgene Regulation.
Rushworth D; Mathews A; Alpert A; Cooper LJ
J Biol Chem; 2015 Sep; 290(38):22970-6. PubMed ID: 26242737
[TBL] [Abstract][Full Text] [Related]
9. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
[TBL] [Abstract][Full Text] [Related]
10. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
[TBL] [Abstract][Full Text] [Related]
11. CLIC1 Induces Drug Resistance in Human Choriocarcinoma Through Positive Regulation of MRP1.
Wu J; Wang D
Oncol Res; 2017 Jul; 25(6):863-871. PubMed ID: 27983917
[TBL] [Abstract][Full Text] [Related]
12. Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.
Morganti M; Coronnello M; Caciagli B; Biondi C; Quattrone A; Capaccioli S; Mazzei T; Mini E
Anticancer Drugs; 2000 Apr; 11(4):285-94. PubMed ID: 10898545
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
Yu S; Wu C; Tan Q; Liu H
J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
[TBL] [Abstract][Full Text] [Related]
14. Large diversity in transport-mediated methotrexate resistance in human leukemia cell line CCRF-CEM established in a high concentration of leucovorin.
Asai S; Miyachi H; Kobayashi H; Takemura Y; Ando Y
Cancer Sci; 2003 Feb; 94(2):210-4. PubMed ID: 12708499
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of methotrexate-sensitivity of choriocarcinoma cells in culture.
Inoue T; Nagura E; Toyoda T; Ishizuka T; Gotoh S; Kawashima K; Tomoda Y; Nagai Y
Jpn J Cancer Res; 1988 Mar; 79(3):400-5. PubMed ID: 2836349
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma.
Jun F; Peng Z; Zhang Y; Shi D
Gynecol Oncol; 2020 Apr; 157(1):268-279. PubMed ID: 31955862
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of resistance to antifolates, a review.
Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
[TBL] [Abstract][Full Text] [Related]
18. Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistance.
Braun SE; McIvor RS; Davidson AS; Hanna M; Traycoff CM; Berebetsky DA; Gonin R; Broxmeyer HE; Cornetta K
Cancer Gene Ther; 1997; 4(1):26-32. PubMed ID: 9012448
[TBL] [Abstract][Full Text] [Related]
19. Effect of methotrexate on the growth and human chorionic gonadotropin secretion of human choriocarcinoma cell lines in vitro.
Sekiya S; Kaiho T; Shirotake S; Iwasawa H; Takeda B; Takamizawa H
Am J Obstet Gynecol; 1983 May; 146(1):57-64. PubMed ID: 6682628
[TBL] [Abstract][Full Text] [Related]
20. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy.
Domin BA; Grill SP; Cheng Y
Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
